UTMD
UTAH MEDICAL PRODUCTS INC
Latest close $71.21 as of Aug 5, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 2 of 2 parsed filing(s)| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Earliest Schedule 13G amendment found | 11 | 12.00% | $63.28 | $61.54 | $71.21 |
| BlackRock Legacy CIK0001364742 | Dec 31, 2023 observed Jan 29, 2024 filed · 29d Schedule 13G amendment | Earliest Schedule 13G amendment found | 204.4K | 5.60% | $71.21 |